-
23-07-2015HIVinnov will co-organise a satelite symposium at the 15th EACS (European AIDS Clinical Society) European AIDS conference in Barcelona on October 20th 2015.
-
16-07-2015This study published by Prof. Miles Davenport from the university of New Wales (Australia) in PLOS Pathogens provides new insights on the frequency of activation among latently...
HIVINNOV (Grant n°305137) is a collaborative research project supported by the European Union
You are here: Home 
News & Events News Dolutegravir works as well as raltegravir for first-time HIV treatment
News & Events News Dolutegravir works as well as raltegravir for first-time HIV treatmentDolutegravir works as well as raltegravir for first-time HIV treatment
January 13th 2013
The next-generation HIV integrase inhibitor dolutegravir worked as well as raltegravir (Isentress), an approved drug in this class, for treatment-naive people in the Phase 3 SPRING-2 trial, according to a report published in the January 8, 2013, advance edition of The Lancet.
Source : The Lancet, hiv&hepatitis,
